欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD44v6 mAbs

简要描述:

The antibody is specific for CD44v6. The antibody recognises an epitope encoded by variant exon v6 of CD44. CD44v6 is a tumor associated antigen abundantly expressed in head and neck squamous cell carcinomas (HNSCC) and in normal squamous epithelium.

产品参数:

Cat. No.:MABL-974

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:in vivo, SPR, therapeutic, ELISA

详细介绍

Key features and details


Cat. No.

MABL-974

Name

Anti-CD44v6 mAbs

Clone No.

AFD- BIWA4

From

Recombinant Antibody

Isotype

Engineer antibody

Application

in vivo, SPR, therapeutic, ELISA

Species Reactivity

Human

Basic Information


Specificity

The antibody is specific for CD44v6. The antibody recognises an epitope encoded by variant exon v6 of CD44. CD44v6 is a tumor associated antigen abundantly expressed in head and neck squamous   cell carcinomas (HNSCC) and in normal squamous epithelium.

Alternative Name

bivatuzumab; CD44 antigen; CDw44; Epican;   Extracellular matrix receptor III; ECMR-III; GP90 lymphocyte homing/adhesion   receptor; HUTCH-I; Heparan sulfate proteoglycan; Hermes antigen; Hyaluronate   receptor; Phagocytic glycoprotein 1; PGP-1; Phagocytic glycoprotein I; PGP-I

UniProt

P16070

Immunogen

The antibody is the humanized version of the   murine BIWA-1.

Application Notes

The binding affinity of the antibody to   CD44v6 was measured by surface plasmon resonance. The antibody showed a   specificity of tumor localization when administrated together with another   anti-CD44v6 antibody in mice in in vivo experiments (Verel et al. 2002; PMID:   11992408). The specificity of the humanized version of the antibody was   confirmed by ELISA anlaysis (Kd= 3.4 nM). The antibody had good therapeutic   efficacy, biodistribution and tumor uptake in in vivo experiments in mice.   Mice treated with 186Re-BIWA 4 showed a decreased in the tumor volume   (US6972324B2). The radioactively labelled humanized version of the antibody   was employed in a clinical trial in patients with advanced squamous cell   carcinoma of the head and neck showing promising antitumor effects (Börjesson   et al., 2003; PMID:  14506195).

Antibody First Published


Note on publication


COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD44 mAbs

下一篇: Anti-CD44v6 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号